US HB7757 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 23 2020 - 25% progression, died in committee
Action: 2020-07-23 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 23 2020 - 25% progression, died in committee
Action: 2020-07-23 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
The bill defines a long-term care pharmacy as a state-licensed pharmacy that is able to provide enhanced pharmacy and clinical services to individuals who have certain comorbid and medically complex chronic conditions and who reside in skilled nursing facilities, nursing facilities, or any other applicable setting (as determined by the CMS). The term enhanced pharmacy and clinical services includes medication dispensed in special packaging, drug utilization review, and 24-7 availability of medication delivery and on-call pharmacists.
Title
Long-Term Care Pharmacy Definition Act of 2020
Sponsors
Rep. Kurt Schrader [D-OR] | Sen. Markwayne Mullin [R-OK] | Rep. Earl Carter [R-GA] | Rep. Tom O'Halleran [D-AZ] |
History
Date | Chamber | Action |
---|---|---|
2020-07-23 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2020-07-23 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2020-07-23 | House | Introduced in House |
Same As/Similar To
SB4259 (Same As) 2020-07-22 - Read twice and referred to the Committee on Finance.
Subjects
Health
Health care coverage and access
Long-term, rehabilitative, and terminal care
Medicare
Prescription drugs
Health care coverage and access
Long-term, rehabilitative, and terminal care
Medicare
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/7757/all-info |
Text | https://www.congress.gov/116/bills/hr7757/BILLS-116hr7757ih.pdf |